Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov ID: NCT05986591

Public ClinicalTrials.gov record NCT05986591. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 12:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-Controlled, Crossover, Single Dose Study To Demonstrate Clinical Pharmacodynamic Bioequivalence of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Bioequivalence Study of Tiotropium Bromide Inhalation Powder 18 μg

Study identification

NCT ID
NCT05986591
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Xiromed LLC
Industry
Enrollment
335 participants

Conditions and interventions

Conditions

Interventions

Combination Product

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 16, 2022
Primary completion
Aug 10, 2023
Completion
Aug 13, 2023
Last update posted
Jan 30, 2024

2022 – 2023

United States locations

U.S. sites
24
U.S. states
10
U.S. cities
22
Facility City State ZIP Site status
DownTown LA Research (West Coast) Los Angeles California 90017
Southwest General Heathcare Fort Myers Florida 33907
SIMED Health Gainesville Florida 32607
Clinical Research Solutions Kissimmee Florida 34744
Clintex Research Group, Inc. Miami Florida 33145
Research Institue of South Florida Miami Florida 33173
Vista Health Research Miami Florida 33176
Velocity Clinical Research - New Smyrna Beach New Smyrna Beach Florida 32132
Southern Clinical Research Zachary Louisiana 70791
Velocity clinical Research Syracuse (East North)) Syracuse New York 13057
Velocity Clinical Research-Cincinnati Cincinnati Ohio 45242
Velocity Clinical Research Grants Pass (W Coast) Grants Pass Oregon 97527
Velocity Clinical Research Medford Medford Oregon 97504
Greater Providence Clinical Research (East North) Cranston Rhode Island 02920
Velocity Clinical Research Anderson Anderson South Carolina 29621
Velocity Clinical Research Columbia Columbia South Carolina 29204
Velocity Clinical Research Gaffney Gaffney South Carolina 29340
Velocity Clinical Research Greenville Greenville South Carolina 29615
Velocity Clinical Research Spartanburg Spartanburg South Carolina 29303
Velocity Clinical Research Union Union South Carolina 29379
Inquest Clinical Research Cypress Texas 77433
Mt. Olympus Medical Research Houston Texas 77479
Sante Clinical Research Kerrville Texas 78028
Velocity Clinical Research-Utah West Jordan Utah 84088

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05986591, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2024 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05986591 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →